A new study suggests that oxytocin doesn’t just promote positive social experiences, but instead may amplify our reactions to experiences both good and bad.
“Understanding how this works in a mouse gives us new ideas on how we could use drugs targeting oxytocin to reduce social anxiety.”
Sometimes called the “love hormone,” oxytocin is a hormone released in the brain that plays a major role in social relationships. The new research shows that after negative social interactions, oxytocin promotes avoidance of unfamiliar social situations.
The researchers worked with female California mice. When stressed, these mice can show a form of social anxiety, staying away from unfamiliar mice instead of approaching. The new study shows that a single dose of a drug that blocks the activity of oxytocin restored normal social behavior in stressed females.
The result is exciting because “for antidepressants like Prozac to have this same effect, it takes a month of daily treatment,” says Trainor, a professor in the University of California, Davis psychology department.
This outcome was expected based on a previous study from the lab, which showed that social stress increased the activity of oxytocin-producing cells in the brain and that females given intranasal oxytocin avoided new social contexts.
Natalia Duque-Wilckens, a postdoctoral researcher who led the study with Trainor, says that these findings support the theory that oxytocin amplifies the effects of social experiences. That is, rather than promoting positive social interactions, oxytocin intensifies the experience of both positive and negative social interactions.
In a positive context, such as with family or friends, oxytocin could promote social approach behavior (hence the “cuddling” hormone). However, in a negative context, like bullying, oxytocin could promote social avoidance. One question left unanswered by this theory is how the same hormone could have such different effects on behavior. The new study provides an explanation.
The team found that two brain regions responded to oxytocin more strongly in females than males. These regions were the bed nucleus of the stria terminalis (BNST), a brain region known to control anxiety, and the nucleus accumbens, a brain region important for reward and motivation.
Duque-Wilckens found that injecting an oxytocin blocker into the BNST, but not the nucleus accumbens, reversed the effects of stress on social behavior in females. Work by other researchers has shown that oxytocin acting in the nucleus accumbens promotes rewarding aspects of social interactions.
Together, these findings suggest that oxytocin can generate social anxiety or reward by acting in different parts of the brain. At times when oxytocin is acting in the BNST, drugs that inhibit oxytocin could reduce social anxiety.
Trainor says a consistent theme in oxytocin research is that experience and the surrounding environment have important effects on how oxytocin affects behavior.
“Stressful social experiences appear to change which parts of the brain use oxytocin,” he says. “Understanding how this works in a mouse gives us new ideas on how we could use drugs targeting oxytocin to reduce social anxiety.”
Additional coauthors are from the Scripps Institute; the University of Indiana; UC Davis; and the Institute of Neuroscience in Milan, Italy. The National Institute of Mental Health and the CONICYT foundation of Chile supported the work.
The researchers report their results in the journal Biological Psychiatry.
Source: UC Davis